Global Blood Preparation Market Research Report 2022
Blood is a mixture of various component including Red Blood Cells (RBC), White Blood Cells (WBC), plasma, and platelets that circulate continuously inside the body to provide nutrition, and oxygen to body, and removes waste from the body.
Due to the COVID-19 pandemic, the global Blood Preparation market size is estimated to be worth US$ 32010 million in 2021 and is forecast to a readjusted size of US$ 41080 million by 2028 with a CAGR of 3.2% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Blood Preparation market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Blood Preparation landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global blood preparation market is expected to grow at a significant growth rate during the forecast period owing to increasing prevalence of blood related diseases that results in growing demand of blood transfusion. Additionally, launch of new anticoagulants in the market, and presence of large unmet needs also boost the global blood preparation market. However, chances of transmission of diseases, allergic reactions, and some other adverse reactions such as hypotensive transfusion reaction, post-transfusion purpura (PTP), and transfusion-associated dyspnea (TAD) can restraint the market. According to WHO, about 5% of HIV infections are transmitted by unsafe transfusion due to unsafe donors, inadequately trained staff, irregular or inadequate supplies of materials to test, poor laboratory testing procedures, and unnecessary transfusions or absence of quality systems.
This report focuses on Blood Preparation volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Blood Preparation market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Blood Preparation Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Whole Blood
Blood Components
Blood Derivatives
Segment by Application
Thrombocytosis
Pulmonary Embolism
Renal Impairment
Angina Blood Vessel Complications
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
GlaxoSmithKline
Baxter Healthcare Corp
Pfizer
Bristol-Myers Squibb Company
Sanofi Aventis
AstraZeneca
Celgene Corporation
Leo Pharma
Due to the COVID-19 pandemic, the global Blood Preparation market size is estimated to be worth US$ 32010 million in 2021 and is forecast to a readjusted size of US$ 41080 million by 2028 with a CAGR of 3.2% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Blood Preparation market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Blood Preparation landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global blood preparation market is expected to grow at a significant growth rate during the forecast period owing to increasing prevalence of blood related diseases that results in growing demand of blood transfusion. Additionally, launch of new anticoagulants in the market, and presence of large unmet needs also boost the global blood preparation market. However, chances of transmission of diseases, allergic reactions, and some other adverse reactions such as hypotensive transfusion reaction, post-transfusion purpura (PTP), and transfusion-associated dyspnea (TAD) can restraint the market. According to WHO, about 5% of HIV infections are transmitted by unsafe transfusion due to unsafe donors, inadequately trained staff, irregular or inadequate supplies of materials to test, poor laboratory testing procedures, and unnecessary transfusions or absence of quality systems.
This report focuses on Blood Preparation volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Blood Preparation market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Blood Preparation Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Whole Blood
Blood Components
Blood Derivatives
Segment by Application
Thrombocytosis
Pulmonary Embolism
Renal Impairment
Angina Blood Vessel Complications
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
GlaxoSmithKline
Baxter Healthcare Corp
Pfizer
Bristol-Myers Squibb Company
Sanofi Aventis
AstraZeneca
Celgene Corporation
Leo Pharma
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
